查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197904

患者註冊軟件市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Patient Registry Software Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

患者登記軟件市場預計在預測期內（2022 年至 2027 年）將以 11.8% 的複合年增長率增長。

COVID-19 預計將對市場增長產生重大影響。 COVID-19 期間的患者登記用於登記患者的 COVID-19 症狀、疫苗試驗的影響、疫苗的上市後許可、疫苗創新的進一步研發活動等。 此外，2020 年 8 月，IQVIA 在 helpstopcovid19.com 上啟動了“COVID 主動研究體驗（CARE）項目”。 IQVIA CARE 項目是一個向公眾開放的選擇加入登記冊，旨在通過分享有關疾病流行、症狀進展和治療結果的信息來提高我們對 COVID-19 的了解。 由患者登記處支持的數據科學創新可以提供一個關鍵的缺失部分來支持 COVID-19 的努力。 因此，預計 COVID-19 將在預測期內影響市場的增長。

推動市場增長的某些因素包括政府實施建立患者登記系統的舉措、越來越多地採用電子健康記錄 (EHR) 以及越來越多地使用患者登記數據進行上市後監測等。

世界各地的市場參與者以創新、經濟高效的方式在醫院內外提供技術驅動、以患者為中心的醫療保健解決方案，以改善 21 世紀的醫療保健成果和質量。我正在尋找更有效的方式。 電子病歷也因其廣泛的臨床和非臨床應用而受到政府部門的關注。 世界上發達國家和發展中國家的政府已經啟動了許多聯邦政策、行動和計劃，以實現醫療保健服務的進步。

在研究期間，全球新患者登記系統的推出以及併購等重大戰略的採用預計將推動市場增長。 例如，2022 年 4 月，Sarner 啟動了一項登記，以收集被診斷患有戈謝病 2 型和 3 型常染色體隱性遺傳病的患者的數據。 我們計劃收集診斷為戈謝病的患者的回顧性和前瞻性臨床和健康結果數據。 我們專注於加速發現、開發和提供促進健康的知識和治療方法。

2022 年 2 月，加拿大神經肌肉疾病登記處為先天性肌無力綜合徵 (CMS) 患者啟動了一個新的登記處。 該登記處旨在改善獲得診斷和治療的機會，並為未來的研究開發加拿大 CMS 隊列。 因此，政府為促進患者登記的採用所做的努力將促進市場的增長。

因此，由於上述因素，研究涵蓋的市場預計在研究期間將會增長。 然而，與隱私和數據安全相關的擔憂正在阻礙全球患者註冊軟件市場的增長。 此外，缺乏訓練有素和熟練的專業人員限制了市場。

患者登記軟件市場趨勢

在患者註冊軟件市場，集成軟件部分預計將佔據主要市場份額。

集成軟件提供多個模塊，以全面提供通常在獨立軟件中可用的功能。 一種業務軟件生產力程序，它將多個應用程序（通常是文字處理、數據庫管理、電子表格、圖形和通信）集成到一個產品中，並允許在所有或大多數模塊之間共享數據。 集成軟件越來越多地用於醫院環境，在這些環境中，不同部門需要記錄多個註冊表，並且部門之間相互共享此數據非常重要。

在 2022 年 2 月發表的一篇文章“臨床文檔改進 (CDI) 的好處是什麼”中，一項調查發現，36% 的臨床醫生每天有一半以上的時間用於管理電子病歷。結果已列出。 72% 的臨床醫生預計在未來 12 個月內將更多時間花在管理任務上。 隨著對臨床文檔的需求預計會增加，對集成患者註冊軟件的需求預計也會增加，從而推動市場增長。

此外，該細分市場新產品的推出將進一步推動市場增長。 例如，2022 年 4 月，加州大學舊金山分校 (UCSF) 與 Quantum Leap Healthcare Collaborative (QLHC) 和美國食品藥品監督管理局 (FDA) 合作開發了 OneSource 系統，以無縫整合臨床護理和研究數據。底部。 OneSource 是一種電子數據採集 (EDC) 系統，旨在從根本上簡化臨床試驗中患者健康數據的收集和分發。

2022 年 2 月，EVERSANA 和 THREAD 推出了面向製藥公司的聯合報價。 該解決方案將 EVERSANA 的集成商業服務、豐富的電子病歷 (EMR) 數據和真實世界數據 (RWD) 驅動的招募能力與 THREAD 領先的去中心化臨床試驗平台相結合，將患者生成的 RWD 與二次生成的 RWD 進行整合和鏈接下一個監管等級。 因此，領先公司採用此類合作夥伴關係和協作將有助於擴大其產品組合併促進該細分市場的增長。

由於上述原因，預計該細分市場在預測期內將出現增長。

北美佔據了很大的市場份額，預計在預測期內也會如此

由於電子病歷普及率上升、政府加大引進患者登記軟件的力度以及製藥公司加大研發活動等因素，北美地區在研究期間將實現強勁增長。預計。

在北美地區，預計美國將主導市場。 在美國，醫療保健數字基礎設施的發展和電子病歷的引入很早就開始了。 例如，在國內，聯邦政府通過各種政策和舉措鼓勵使用其醫療保健數據。

在 2022 年 1 月發表的一篇文章“How A Clinical Data Registry Can Work With Your EHR”中，數據註冊信息可以幫助指導患有相同疾病或病症的患者採取最有效的治療策略。建議幫助臨床醫生在做出選擇時。 它還允許臨床醫生實時探索患者群體的趨勢，例如，查看新療法與現有療法相比是否有效。 因此，患者登記的好處將推動國內採用並推動市場。

此外，患者登記市場將受到新產品和軟件發布的推動。 2022 年 5 月，國家胰腺基金會 (NPF) 與 SeqsterOS 合作啟動了胰腺病患者登記系統。 這個以患者為中心的登記系統將為患者及其護理人員提供使用來自任何 EHR、基因組 DNA 測試和可穿戴/遠程監控設備的實時數據創建縱向患者記錄的能力。

此外，2022 年 3 月，罕見病臨床研究網絡 (RDCRN) 啟動了一個聯繫人註冊中心，以將罕見病患者與研究人員聯繫起來並推進罕見病研究。 該登記處收集並維護希望提供罕見病研究信息的人員的聯繫信息。 我們還將讓您了解參與研究的機會。 因此，在該國推出此類服務將有助於患者數據整合，並可能有助於推動市場的臨床試驗。

因此，由於上述因素，所研究的市場有望在研究期間推動該地區的市場。

患者註冊軟件市場競爭對手分析

患者登記軟件市場的競爭很低。 產品發布和主要參與者採用關鍵戰略等因素推動了市場參與者。 Dacima Software Inc.、FIGmd, Inc.、Global Vision Technologies, Inc.、Image Trend, Inc.、IQVIA、Liasion Technologies、McKesson Corporation、Synos□□ Health 和 Velos Inc. 等公司在市場上佔有重要的市場份額學習了。持有

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 實施政府建立患者登記系統的舉措
    • 電子健康記錄 (EHR) 普及率上升
    • 在上市後監測中更多地使用患者登記數據
  • 市場製約因素
    • 隱私和數據安全問題
    • 缺乏訓練有素的技術人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（按價值劃分的市場規模：單位：百萬美元）

  • 按註冊表類型
    • 疾病登記
    • 醫療服務登記處
    • 產品註冊
  • 按軟件類型
    • 獨立軟件
    • 集成軟件
  • 最終用戶
    • 醫院
    • 政府機構和第三方 (TPA)
    • 製藥公司、生物技術公司、醫療器械公司
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Dacima Software Inc.
    • FIGmd Inc.
    • Global Vision Technologies Inc.
    • Image Trend Inc.
    • IQVIA
    • Ordinal Data, Inc.
    • McKensson Corporation
    • Syneos Health
    • Velos Inc.
    • Cerner Corporation
    • IBM
    • ArborMetrix

第7章 市場機會與今後動向

簡介目錄
Product Code: 46278

The patient registry software market is expected to witness a CAGR of 11.8% during the forecast period (2022-2027).

COVID-19 is expected to have a significant impact on the growth of the market. The patient registry during COVID-19 was used to register the symptoms of COVID-19 in the patients, the impact of vaccination trials, post-marketing authorization of vaccines, and further research and development activities in innovating vaccines. Furthermore, in August 2020, IQVIA launched its COVID Active Research Experience (CARE) Project at helpstopcovid19.com. The IQVIA CARE Project is an opt-in registry available to anyone to advance understanding of COVID-19 through shared information about disease prevalence, symptom progression, and treatment outcomes. Data science innovations supported by patient registries can provide critical missing pieces to support COVID-19 efforts. Thus, COVID-19 is expected to impact the growth of the market during the forecast period.

Certain factors that are driving the market growth include the implementation of government initiatives to build patient registries, the rising adoption of electronic health records (EHR), and the increasing use of patient registry data for post-marketing surveillance.

Owing to the improved outcomes and quality of care in the 21st century, market players around the world are looking for innovative and cost-effective ways to deliver technology-enabled, patient-centered healthcare solutions, both inside and outside hospital walls. Due to widespread applications, including clinical and non-clinical, electronic health records have been able to attract attention from government sources. Many federal policies, actions, and programs are being initiated by the government of developed and developing countries across the world to experience progress in healthcare services.

The launch of new patient registries across the world and the adoption of key strategies, like mergers and acquisitions, are expected to drive market growth during the study period. For instance, in April 2022, Cerner launched a registry that will collect data from patients diagnosed with Type 2 and Type 3 Gaucher disease, an autosomal recessive disease. It will collect retrospective and prospective clinical and health outcome data for patients diagnosed with Gaucher disease. It is focused on accelerating the discovery, development, and delivery of insights and therapies to improve health.

In February 2022, Canadian Neuromuscular Disease Registry launched a new registry for patients with congenital myasthenic syndrome (CMS). This registry aims to improve access to diagnosis and treatment and develop a Canadian CMS cohort for future research. Thus, such government initiatives boosting the adoption of patient registries will boost market growth.

Thus, due to the above-mentioned factors, the studied market is expected to augment during the study period. However, concerns relating to privacy and data security are inhibiting the growth of the global patient registry software market. Moreover, the lack of trained and skilled professionals is limiting the market.

Patient Registry Software Market Trends

Integrated Software Segment is is Expected to Hold a Major Market Share in the Patient Registry Software Market

Integrated software provides multiple modules offering a comprehensive range of features normally available in stand-alone software. A business software productivity program that incorporates several applications (typically word processing, database management, spreadsheet, graphics, and communications) into one product, allowing data sharing between all or most modules. Integrated software is being increasingly used in hospital settings, where multiple registries need to be recorded in different departments, and cross-sharing of this data across departments is crucial.

The article "What Are the Benefits of Clinical Documentation Improvement (CDI)?" published in February 2022, stated the result of a survey stated that 36% of clinicians spend more than half their day on administrative tasks in Electronic Health Records. 72% of clinicians expect the time they spend on administrative tasks to increase over the next 12 months. Due to the expected increase in the required clinical documentation, there will be an increase in demand for integrated patient registry software, which will boost the market growth.

Additionally, the launch of new products in the segment will further drive market growth. For instance, in April 2022, UC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the United States Food and Drug Administration (FDA), developed the OneSource system to seamlessly integrate clinical care and research data. OneSource is an electronic data capture (EDC) system that was developed to radically streamline the collection and distribution of patient health data for clinical trials.

In February 2022, EVERSANA and THREAD launched a combined offering for pharmaceutical companies. This solution combines EVERSANA's integrated commercial services, rich electronic medical record (EMR) data, and real-world data (RWD) driven recruitment capabilities with THREAD's leading decentralized clinical trial platform to aggregate and link patient-generated and secondary regulatory-grade RWD. Thus, the adoption of such partnerships and collaborations by major players will help in expanding their product portfolio and contribute to segment growth.

Thus, owing to the above factors, the segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North American region is expected to register significant growth during the study period owing to the factors such as the rising adoption of electronic health records, rise in government initiatives for the adoption of patient registry software, and rise in research and development activities by pharmaceutical companies.

The United States within the North American region is expected to dominate the market. In the United States, digital infrastructure development for healthcare and electronic health record adoption started earlier. For example, within the country, the federal government has been encouraging the use of its healthcare data through various policies and initiatives.

The article "How A Clinical Data Registry Can Work With Your EHR," published in January 2022, suggests that information in a data registry is used to help clinicians in choosing the most effective course of treatment for patients suffering from the same disease or condition. It also allows clinicians to investigate trends in the patient population in real-time, for instance, seeing if a new therapy is effective or not when compared to existing treatments. Thus, the benefits of a patient registry will increase the adoption of them in the country, thus driving the market.

Additionally, the launch of new products and software in the patient registry market will drive the market. In May 2022, The National Pancreas Foundation ("NPF") launched the pancreatic disease patient registry in partnership with SeqsterOS. The patient-centric registry gives patients and their caregivers the ability to create their longitudinal patient records with real-time data from any EHR, genomic DNA test, and wearable/remote monitoring device.

Moreover, in March 2022, The Rare Diseases Clinical Research Network (RDCRN) launched a contact registry to connect rare disease patients with researchers and advance rare disease research. The registry will collect and maintain the contact information of people who want to receive information about rare disease research. It will also inform participants about opportunities to participate in research. Thus, such launches in the country will help in integrating patient data, which might further help in clinical trials and drive the market.

Thus, due to the above-mentioned factors, the studied market is expected to drive the market in the region during the study period.

Patient Registry Software Market Competitor Analysis

The patient registry software market is moderately competitive. Factors such as product launches and the adoption of key strategies by major players will lead the market players to drive the market. Companies, like Dacima Software Inc., FIGmd, Inc., Global Vision Technologies, Inc., Image Trend, Inc., IQVIA, Liasion Technologies, McKesson Corporation, Syneos Health, and Velos Inc., among others, hold a substantial market share in the market studied.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Implementation of Government Initiatives to Build Patient Registries
    • 4.2.2 Rising Adoption of Electronic Health Records (EHR)
    • 4.2.3 Increasing Use of Patient Registry Data for Post-marketing Surveillance
  • 4.3 Market Restraints
    • 4.3.1 Privacy and Data Security-related Concerns
    • 4.3.2 Lack of Trained and Skilled Resources
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Type of Registry
    • 5.1.1 Disease Registries
    • 5.1.2 Health Service Registries
    • 5.1.3 Product Registries
  • 5.2 By Type of Software
    • 5.2.1 Stand-alone Software
    • 5.2.2 Integrated Software
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Government Organizations and Third Party Administrators (TPAs)
    • 5.3.3 Pharmaceutical, Biotechnology, and Medical Device Companies
    • 5.3.4 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Dacima Software Inc.
    • 6.1.2 FIGmd Inc.
    • 6.1.3 Global Vision Technologies Inc.
    • 6.1.4 Image Trend Inc.
    • 6.1.5 IQVIA
    • 6.1.6 Ordinal Data, Inc.
    • 6.1.7 McKensson Corporation
    • 6.1.8 Syneos Health
    • 6.1.9 Velos Inc.
    • 6.1.10 Cerner Corporation
    • 6.1.11 IBM
    • 6.1.12 ArborMetrix

7 MARKET OPPORTUNITIES AND FUTURE TRENDS